Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open …, 2020 - openheart.bmj.com
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
[PDF][PDF] Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - academia.edu
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open Heart, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> To assess the safety (ie, risk of
bleeding) and effectiveness (ie, risk of stroke/systemic embolism (SE)) separately for four …
bleeding) and effectiveness (ie, risk of stroke/systemic embolism (SE)) separately for four …
[HTML][HTML] Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open Heart, 2020 - ncbi.nlm.nih.gov
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: A retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open …, 2020 - keio.elsevierpure.com
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open Heart, 2020 - europepmc.org
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: A retrospective analysis of …
S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open …, 2020 - keio.elsevierpure.com
Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …